Aging & Disability Vaccine Collaborative

Logo for the Aging & Disability Vaccine Collaborative Powered by USAging


Living Independently for Today & Tomorrow (LIFTT) is pleased to be a part of the Aging and Vaccine Disability Collaborative (ADVC).

Funded through a grant from USAging, the ADVC is a nationwide alliance of organizations dedicated to providing greater person-centered access to vaccines such as COVID-19 and influenza to the aging and disabled community.

As an ADVC partner, LIFTT Team Members are able to provide assistance to consumers who need assistance locating a vaccination site, scheduling an appointment, getting transportation to and from a vaccination site, or obtaining accurate information about COVID-19, influenza, and other vaccines.

For more information about the ADVC, you can download our flyer by clicking on the image below (Adobe PDF), view the video on this page, or contact your local LIFTT office:

In Big Horn County, Carbon, Garfield, Golden Valley, Musselshell, Rosebud, Stillwater, Treasure, or Yellowstone Counties, contact the Billings LIFTT office at (406) 259-5181. In Carter, Custer Dawson, Fallon, McCone, Powder River, Prairie, Richland, or Wibaux Counties, contact the  Glendive LIFTT Office at (406) 948-8500.

You can also reach out to us from anywhere through our website contact page or via our LIFTT App for Apple and Android.  Remember to consult your primary healthcare provider about if a particular treatment is appropriate for you individually.

Aging and Disability Community Collaboration: Vaccines and Beyond

On this edition of “Living Well in Montana” LIFTT Executive Director Carlos Ramalho and Communications Coordinator Jed Barton visit with Sandy Markwood, Chief Executive Officer of USAging.

The discussion focused on the increasing collaboration between the aging and disability communities including LIFTT”s participation in the Aging & Disability Vaccine Collaborative to help ensure that seniors and persons with disabilities have accurate information about and appropriate access to vaccines for Influenza and COVID-19.